🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 19 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
01/09/2004 16,44 16,44 15,12 15,54 -4,43% 8,03% 36.067
31/08/2004 15,78 16,44 15,42 16,26 +2,26% 6,46% 41.617
30/08/2004 14,82 16,44 14,46 15,90 +10,42% 13,36% 97.517
27/08/2004 14,10 14,40 13,98 14,40 +3,00% 2,98% 34.583
26/08/2004 13,92 14,16 13,26 13,98 +0,43% 6,47% 17.183
25/08/2004 14,58 14,76 13,50 13,92 -2,93% 8,64% 43.400
24/08/2004 13,20 15,18 13,08 14,34 +12,21% 15,91% 117.200
23/08/2004 13,20 13,50 12,42 12,78 +0,95% 8,18% 27.850
20/08/2004 11,94 12,90 11,64 12,66 +5,50% 10,55% 34.467
19/08/2004 12,00 12,00 11,52 12,00 +2,04% 4,00% 14.700
18/08/2004 11,52 12,06 11,16 11,76 +4,26% 7,81% 18.900
17/08/2004 10,50 12,00 10,50 11,28 +5,62% 14,29% 33.267
16/08/2004 10,56 10,80 9,90 10,68 +1,14% 8,52% 16.450
13/08/2004 10,02 10,80 9,84 10,56 +6,67% 9,58% 13.567
12/08/2004 10,02 10,44 9,84 9,90 -1,20% 5,99% 22.450
11/08/2004 9,90 10,50 9,48 10,02 -1,76% 10,30% 22.783
10/08/2004 9,60 10,20 9,42 10,20 +6,92% 8,12% 88.450
09/08/2004 9,36 10,26 9,30 9,54 -0,63% 10,26% 40.067
06/08/2004 10,08 10,26 9,36 9,60 -8,57% 8,93% 50.633
05/08/2004 10,62 10,98 10,20 10,50 -2,23% 7,34% 27.133
04/08/2004 11,16 11,64 10,50 10,74 -5,79% 10,22% 20.883
03/08/2004 11,64 11,64 11,10 11,40 +0,53% 4,64% 11.033
02/08/2004 11,76 11,94 11,16 11,34 -6,44% 6,63% 16.767
30/07/2004 11,70 12,24 11,40 12,12 +0,50% 7,18% 13.383
29/07/2004 11,76 12,06 11,52 12,06 +1,01% 4,59% 15.617
28/07/2004 11,10 12,18 9,66 11,94 +6,99% 22,70% 58.667
27/07/2004 11,10 11,46 10,56 11,16 -1,06% 8,11% 17.133
26/07/2004 11,82 11,94 10,50 11,28 -1,57% 12,18% 24.100
23/07/2004 12,06 12,24 11,40 11,46 -4,50% 6,97% 32.000
22/07/2004 11,82 12,60 11,82 12,00 +0,00% 6,60% 29.850